Bicara Therapeutics Inc. Common Stock
BCAX | NASDAQ
$22.61
+$0.60 (+2.73%)
Sep 22, 2026, 10:29 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PE Ratio | -9.58 | -7.15 | -6.65 | -7.08 | -4.94 | -7.90 | -14.05 | -23.37 | -19.67 | -21.88 | -24.64 | -32.51 | -78.03 | -156.07 |
PEG Ratio | 0.81 | -0.19 | -4.46 | -0.21 | 0.19 | -0.10 | -0.75 | -1.26 | n/a | -1.26 | 0.54 | -0.18 | n/a | n/a |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 4.30 | 2.35 | 2.31 | 2.14 | 1.16 | 1.55 | 1.93 | 2.72 | -7.26 | 6.59 | 5.69 | n/a | n/a | -73.98 |
P/FCF Ratio | -14.91 | -10.36 | -8.66 | -7.62 | -5.02 | -8.03 | -12.67 | -26.04 | -27.18 | -26.83 | -26.89 | -33.75 | -47.24 | -94.47 |
P/OCF Ratio | -14.96 | -10.39 | -8.69 | -7.63 | -5.02 | -8.04 | -12.69 | -26.27 | -27.54 | -27.17 | -27.24 | -33.88 | -47.24 | -94.47 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | n/a | n/a | n/a |
Quick Ratio | 11.59 | 13.85 | 14.58 | 14.14 | 25.80 | 24.62 | 27.93 | 36.01 | 12.83 | 12.83 | 15.32 | n/a | n/a | n/a |
Current Ratio | 11.59 | 13.85 | 14.58 | 14.14 | 25.80 | 24.62 | 27.93 | 36.01 | 12.83 | 12.83 | 15.32 | n/a | n/a | n/a |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -11.83% | -10.94% | -9.31% | -9.02% | -6.29% | -8.03% | -4.26% | -3.43% | 9.75% | -6.50% | -5.69% | n/a | n/a | 48.33% |
Return on Assets | -10.82% | -10.15% | -8.67% | -8.55% | -6.04% | -7.71% | -3.68% | -3.33% | -8.17% | -5.99% | -5.32% | n/a | n/a | n/a |
Return on Invested Capital | -12.76% | -11.68% | -10.20% | -10.05% | -7.32% | -9.09% | -4.83% | -4.04% | -10.23% | -7.97% | -6.24% | n/a | n/a | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove BCAX